NeuroLogica Corp. has received FDA approval for their portable, full-body, multi-slice CT scanner known as the BodyTom, the company announced this week.
NeuroLogica Corp. has received FDA approval for their portable, full-body, multi-slice CT scanner known as the BodyTom, the company announced this week.
The machine, which the company says is the first of its kind, received 501(k) clearance. The BodyTom is a battery-powered 32-slice CT with an 85 cm gantry and 60cm field of view, and it’s designed to be transported from room to room. It is DICOM 3.1 compliant and compatible with PACS, and other systems, the company said.
“Bringing high resolution imaging technology to the patient rather than moving patients to obtain this kind of vital information for a broad range of applications has to be the future," Dr. Howard Yonas, Chief of Neurosurgery at University of New Mexico Medical Center, said in the company press release. "The ability to bring such a powerful and high quality 32 slice CT scanner into the operating room for intra-operative scanning should have a significant impact on improving care and surgical outcomes.”
The Danvers, Mass.-based company also developed the portable head CT scanner, CereTom. The mobile unit was designed to scan patients suspected of traumatic brain injury and can fit through hospital doorways to perform scans from perfusion imaging to CT angiography.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
Can CT-Based Deep Learning Bolster Prognostic Assessments of Ground-Glass Nodules?
June 19th 2025Emerging research shows that a multiple time-series deep learning model assessment of CT images provides 20 percent higher sensitivity than a delta radiomic model and 56 percent higher sensitivity than a clinical model for prognostic evaluation of ground-glass nodules.